Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction

Detalhes bibliográficos
Autor(a) principal: Marta, Ana
Data de Publicação: 2021
Outros Autores: Baptista, Pedro Manuel, Marques, Joao Heitor, Almeida, Daniel, José, Diana, Sousa, Paulo, Barbosa, Irene
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.16/2827
Resumo: Purpose: To analyse the clinical outcome in patients with meibomian gland dysfunction (MGD) who underwent intense pulsed light (IPL) plus low-level light therapy (LLL). Materials and methods: The prospective non-comparative study included identified by MGD patients with altered interferometry and lower loss area of the meibomian glands (LAMG), who underwent IPL plus LLL, between July 2020 and August 2020. A multimodal assessment was performed before, 2-3 weeks, and 6 months after treatment. The main outcome was lipid layer thickness (LLT) and the secondary outcomes were the ocular surface disease index (OSDI) score, presence of corneal fluorescein staining (CFS), blink rate (BR), Schirmer test (ST), tear meniscus height (TMH), tear osmolarity (OSM), non-invasive break-up time (NIBUT) and LAMG. Results: This study included 62 eyes of 31 patients, 61.3% female, with a mean age of 66.94±9.08 years at the time of IPL plus LLL treatment. LLT (<0.001) grades improved 6 months after treatment. The mean OSDI score improved (p<0.001) from 45.02±21.17 (severe symptoms) to 22.35±17.68 (moderate symptoms) at 2-3 weeks and 8.24±17.9.91 (normal) at 6 months after treatment. CFS was identified in 51.6% (32/62) before and in 45.2% (28/62) 6 months (p=0.293) after treatment. ST (p=0.014) grades improved; OSM grades mild worsened (p<0.001); TMH, NIBUT and LAMG grades did not modify 6 months after treatment. No patient suffered any adverse effects. Conclusion: IPL combined with LLL was effective and safe, improving the lipid layer thickness in MGD and decreasing the level of symptoms.
id RCAP_6e9284f8eef3d8b947cd0835edfd56ce
oai_identifier_str oai:repositorio.chporto.pt:10400.16/2827
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland DysfunctionOSDIdry eye diseaseintense pulsed lightevel low light treatmentlipid layer thicknessmeibomian gland dysfunctionPurpose: To analyse the clinical outcome in patients with meibomian gland dysfunction (MGD) who underwent intense pulsed light (IPL) plus low-level light therapy (LLL). Materials and methods: The prospective non-comparative study included identified by MGD patients with altered interferometry and lower loss area of the meibomian glands (LAMG), who underwent IPL plus LLL, between July 2020 and August 2020. A multimodal assessment was performed before, 2-3 weeks, and 6 months after treatment. The main outcome was lipid layer thickness (LLT) and the secondary outcomes were the ocular surface disease index (OSDI) score, presence of corneal fluorescein staining (CFS), blink rate (BR), Schirmer test (ST), tear meniscus height (TMH), tear osmolarity (OSM), non-invasive break-up time (NIBUT) and LAMG. Results: This study included 62 eyes of 31 patients, 61.3% female, with a mean age of 66.94±9.08 years at the time of IPL plus LLL treatment. LLT (<0.001) grades improved 6 months after treatment. The mean OSDI score improved (p<0.001) from 45.02±21.17 (severe symptoms) to 22.35±17.68 (moderate symptoms) at 2-3 weeks and 8.24±17.9.91 (normal) at 6 months after treatment. CFS was identified in 51.6% (32/62) before and in 45.2% (28/62) 6 months (p=0.293) after treatment. ST (p=0.014) grades improved; OSM grades mild worsened (p<0.001); TMH, NIBUT and LAMG grades did not modify 6 months after treatment. No patient suffered any adverse effects. Conclusion: IPL combined with LLL was effective and safe, improving the lipid layer thickness in MGD and decreasing the level of symptoms.Dove Medical PressRepositório Científico do Centro Hospitalar Universitário de Santo AntónioMarta, AnaBaptista, Pedro ManuelMarques, Joao HeitorAlmeida, DanielJosé, DianaSousa, PauloBarbosa, Irene2023-10-19T11:49:36Z2021-062021-06-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/2827engMarta A, Baptista PM, Heitor Marques J, et al. Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction. Clin Ophthalmol. 2021;15:2803-2811. doi:10.2147/OPTH.S3188851177-546710.2147/OPTH.S318885info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-20T11:05:12Zoai:repositorio.chporto.pt:10400.16/2827Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:39:00.101762Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
title Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
spellingShingle Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
Marta, Ana
OSDI
dry eye disease
intense pulsed light
evel low light treatment
lipid layer thickness
meibomian gland dysfunction
title_short Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
title_full Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
title_fullStr Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
title_full_unstemmed Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
title_sort Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction
author Marta, Ana
author_facet Marta, Ana
Baptista, Pedro Manuel
Marques, Joao Heitor
Almeida, Daniel
José, Diana
Sousa, Paulo
Barbosa, Irene
author_role author
author2 Baptista, Pedro Manuel
Marques, Joao Heitor
Almeida, Daniel
José, Diana
Sousa, Paulo
Barbosa, Irene
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Centro Hospitalar Universitário de Santo António
dc.contributor.author.fl_str_mv Marta, Ana
Baptista, Pedro Manuel
Marques, Joao Heitor
Almeida, Daniel
José, Diana
Sousa, Paulo
Barbosa, Irene
dc.subject.por.fl_str_mv OSDI
dry eye disease
intense pulsed light
evel low light treatment
lipid layer thickness
meibomian gland dysfunction
topic OSDI
dry eye disease
intense pulsed light
evel low light treatment
lipid layer thickness
meibomian gland dysfunction
description Purpose: To analyse the clinical outcome in patients with meibomian gland dysfunction (MGD) who underwent intense pulsed light (IPL) plus low-level light therapy (LLL). Materials and methods: The prospective non-comparative study included identified by MGD patients with altered interferometry and lower loss area of the meibomian glands (LAMG), who underwent IPL plus LLL, between July 2020 and August 2020. A multimodal assessment was performed before, 2-3 weeks, and 6 months after treatment. The main outcome was lipid layer thickness (LLT) and the secondary outcomes were the ocular surface disease index (OSDI) score, presence of corneal fluorescein staining (CFS), blink rate (BR), Schirmer test (ST), tear meniscus height (TMH), tear osmolarity (OSM), non-invasive break-up time (NIBUT) and LAMG. Results: This study included 62 eyes of 31 patients, 61.3% female, with a mean age of 66.94±9.08 years at the time of IPL plus LLL treatment. LLT (<0.001) grades improved 6 months after treatment. The mean OSDI score improved (p<0.001) from 45.02±21.17 (severe symptoms) to 22.35±17.68 (moderate symptoms) at 2-3 weeks and 8.24±17.9.91 (normal) at 6 months after treatment. CFS was identified in 51.6% (32/62) before and in 45.2% (28/62) 6 months (p=0.293) after treatment. ST (p=0.014) grades improved; OSM grades mild worsened (p<0.001); TMH, NIBUT and LAMG grades did not modify 6 months after treatment. No patient suffered any adverse effects. Conclusion: IPL combined with LLL was effective and safe, improving the lipid layer thickness in MGD and decreasing the level of symptoms.
publishDate 2021
dc.date.none.fl_str_mv 2021-06
2021-06-01T00:00:00Z
2023-10-19T11:49:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/2827
url http://hdl.handle.net/10400.16/2827
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Marta A, Baptista PM, Heitor Marques J, et al. Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction. Clin Ophthalmol. 2021;15:2803-2811. doi:10.2147/OPTH.S318885
1177-5467
10.2147/OPTH.S318885
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Dove Medical Press
publisher.none.fl_str_mv Dove Medical Press
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133650312232960